Transplantation of Astrocytic Mitochondria Modulates Neuronal Antioxidant Defense and Neuroplasticity and Promotes Functional Recovery after Intracerebral Hemorrhage.
Tashiro. Ryosuke R; Bautista-Garrido. Jesus J; Ozaki. Dan D; Sun. Guanghua G; Obertas. Lidiya L; Mobley. Alexis S AS; Kim. Gab Seok GS; Aronowski. Jaroslaw J; Jung. Joo Eun JE
Key Findings
- Astrocyte‑derived mitochondria enter neurons and restore Mn‑SOD levels after intracerebral hemorrhage
- Mitochondrial transfer reduces oxidative stress, neuronal death, and improves functional recovery in mice
- The mitochondrial peptide humanin alone can mimic the protective effects on antioxidant defense and neuroplasticity
Practical Outcomes
- Humanin shows promise as a neuroprotective agent that could enhance antioxidant defenses, but it’s still early‑stage animal research. For biohackers, the takeaway is that targeting mitochondrial health and peptides like humanin may someday support brain resilience, though no dosing or safe human protocols exist yet.
Summary
Scientists found that mitochondria released by brain support cells can travel into neurons, boost a key antioxidant enzyme (Mn‑SOD), cut oxidative damage, and help brain cells grow after a bleed. A tiny protein inside mitochondria called humanin can copy these benefits, suggesting it might protect brain cells from stress.
Abstract
Astrocytes release functional mitochondria (Mt) that play regulatory and prosurvival functions on entering adjacent cells. We recently demonstrated that these released Mts could enter microglia to promote their reparative/prophagocytic phenotype that assists in hematoma cleanup and neurological recovery after intracerebral hemorrhage (ICH). However, the relevance of astrocytic Mt transfer into neurons in protecting brain after ICH is unclear. Here, we found that ICH causes a robust increase in superoxide generation and elevated oxidative damage that coincides with loss of the mitochondrial enzyme manganese superoxide dismutase (Mn-SOD). The damaging effect of ICH was reversed by intravenous transplantation of astrocytic Mt, which on entering the brain (and neurons), restored Mn-SOD levels and reduced neurological deficits in male mice subjected to ICH. Using an <i>in vitro</i> ICH-like injury model in cultured neurons, we established that astrocytic Mt on entering neurons prevented reactive oxygen species-induced oxidative stress and neuronal death by restoring neuronal Mn-SOD levels while at the same time promoted neurite extension and upregulation of synaptogenesis-related gene expression. Furthermore, we found that Mt genome-encoded small peptide humanin, which is normally abundant in Mt, could simulate Mt-transfer effect on neuronal Mn-SOD expression, oxidative stress, and neuroplasticity under ICH-like injury. This study demonstrates that adoptive astrocytic Mt transfer enhances neuronal Mn-SOD-mediated antioxidative defense and neuroplasticity in the brain, which potentiate functional recovery following ICH.<b>SIGNIFICANCE STATEMENT</b> Mitochondrial dysfunction and antioxidant defense play essential roles in brain damage after ICH. Astrocytes release functional Mt that enters adjacent cells to help brain homeostatic function. Here, we show that systemic transplantation of astrocytic Mt restores ICH-impaired neuronal antioxidative defense, enhances neurite outgrowth, and improves stroke recovery after ICH. Our study suggests that systemic transplantation of astrocytic Mt could be considered as a novel and potentially promising strategy for ICH treatment.
Study Information
pubmed
2022
2022-09-07T00:00:00.000Z
10.1523/jneurosci.2222-21.2022